Beijing, China 4/29/14—Global alternative-asset manager the Carlyle Group has agreed to acquire a 30% stake in Haier Bio-Medical and Laboratory (HBML) for CNY 405 million ($65 million = CNY 6.23 = $1) through its Carlyle Beijing Partners Fund. A subsidiary of Haier, HBML develops and manufactures biomedical and lab equipment for the Chinese and global […]
Washington, DC 4/16/14—Danaher has named Executive Vice President Thomas P. Joyce, Jr. to succeed H. Lawrence Culp, Jr. as president and CEO. Mr. Culp will retire on March 1, 2015. Mr. Joyce is currently responsible for Danaher’s Water Quality, Life Sciences and Diagnostics platforms, which have combined annual revenues of over $9 billion. “During Larry’s […]
Company Announcements Sony announced in January the establishment with M3 of a new company, P5, which will launch a genomic-information platform in Japan for genome analysis services for research institutes and enterprises. It will also provide a service platform to support the use of genetic data for personalized medicine. Illumina is a minority investor. In […]
On April 15, the European Parliament approved €22 billion ($30.4 billion) in funds for the “innovation investment package” of Horizon 2020. Programs include public-private partnerships for the Innovative Medicines Initiative (IMI 2), Fuel Cells and Hydrogen 2, Clean Sky 2 and Bio-Based Industries. Recipients of funding will be determined competitively. Public-public partnership areas include the […]
A working group of experts assembled by the US National Human Genome Research Institute has published guidelines for studying how variations in genetic sequence may cause disease in humans. Not all variations play a role in disease, and incorrect assessment of variants can have adverse effects, including incorrect treatments for patients. The guidelines apply to […]
The US equity markets wavered in April as a result of mixed earnings and economic data. While manufacturing reports and consumer sentiment improved, the housing markets and GDP growth concerned investors. First quarter US GDP grew at a lackluster 0.1%, which was below analysts’ expectations of 1.1% and significantly lower than the 2.6% growth in […]
Settlements dominate this spring’s look at patent infringement litigation among instrument and lab product firms. New suits were filed targeting Luminex and microscopy companies. New Suits Last November, Irori Technologies, a supplier of combinatorial chemistry systems, filed suit in Southern California District Court against Luminex (see table). The complaint alleged infringement of three patents by […]
Indianapolis, IN 4/22/14—Beckman Coulter Life Sciences has agreed to acquire Xitogen Technologies, a China-based flow cytometer company, together with Cytojene, for an undisclosed amount. Xitogen offers the XTG-1600 compact flow cytometer designed for basic research applications for the detection of objects in the 100 nm range. Beckman stated that Xitogen’s facilities in Suzhou and Dalian […]
The first of IBO’s biannual new-laboratory roundups focuses on large new academic buildings and facilities for food testing. In addition, the table on page 6 highlights plans for selected new academic translational-research labs, consumer-products labs and pharmaceutical labs. Several US universities are building or have plans for science facilities at least 200,000 ft2 in size. […]
The American Association for Cancer Research (AACR) hosted its annual conference from April 5 to 9 in San Diego, California. Attendance for the conference was up 2% from last year, when it was held in Washington, DC, to over 18,400 attendees. The number of exhibitors rose 4% to 3,057. On Monday afternoon, the AACR/American Society […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
